ROIV
Roivant Sciences Ltd. · Healthcare
CEO Matthew Gline bought $50K of Roivant Sciences Ltd.
Bought$49,957
$15.07Price
3,315Shares
What ROIV did for a copier
- $1,000 copied at Fri, Sep 19 open, $15.18
- $1,317
- S&P 500, same days
- +3.0%
Measured over 30 trading days, to the Oct 31 close.
Matthew Gline's record
No other buys on record. A record shows here once 3 buys have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Thu, Sep 18. Filed Thu, Sep 18, 7:28 PM ET, after the close. Returns use the Sep 19 open and the Oct 31 close. Not investment advice.